SEARCH

SEARCH BY CITATION

References

  • Anasetti, C., Petersdorf, E.W., Martin, P.J., Woolfrey, A. & Hansen, J.A. (2000) Improving availability and safety of unrelated donor transplants. Current Opinion in Oncology, 12, 121126.
  • Andersen, P.K., Klein, J.P. & Zhang, M.J. (1999) Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Statistics in Medicine, 18, 14891500.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 460462.
  • Bloomfield, C.D., Lawrence, D., Byrd, J.C., Carroll, A., Pettenati, M.J., Tantravahi, R., Patil, S.R., Davey, F.R., Berg, D.T., Schiffer, C.A., Arthur, D.C. & Mayer, R.J. (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Research, 58, 41734179.
  • Breems, D.A. & Lowenberg, B. (2005) Autologous stem cell transplantation in the treatment of adults with acute myeloid leukaemia. British Journal of Haematology, 130, 825833.
  • Burnett, A.K., Goldstone, A.H., Stevens, R.M., Hann, I.M., Rees, J.K., Gray, R.G. & Wheatley, K. (1998) Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet, 351, 700708.
  • Busca, A., Anasetti, C., Anderson, G., Appelbaum, F.R., Buckner, C.D., Doney, K., Martin, P.J., Petersdorf, E., Sanders, J.E. & Hansen, J.A. (1994) Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood, 83, 30773084.
  • Cassileth, P.A., Harrington, D.P., Hines, J.D., Oken, M.M., Mazza, J.J., McGlave, P., Bennett, J.M. & O'Connell, M.J. (1988) Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. Journal of Clinical Oncology, 6, 583587.
  • Cassileth, P.A., Andersen, J., Lazarus, H.M., Colvin, O.M., Bennett, J.M., Stadtmauer, E.A., Kaizer, H., Weiner, R.S., Edelstein, M. & Oken, M.M. (1993) Autologous bone marrow transplant in acute myeloid leukemia in first remission. Journal of Clinical Oncology, 11, 314319.
  • Cassileth, P.A., Harrington, D.P., Appelbaum, F.R., Lazarus, H.M., Rowe, J.M., Paietta, E., Willman, C., Hurd, D.D., Bennett, J.M., Blume, K.G., Head, D.R. & Wiernik, P.H. (1998) Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. New England Journal of Medicine, 339, 16491656.
  • Cheson, B.D., Cassileth, P.A., Head, D.R., Schiffer, C.A., Bennett, J.M., Bloomfield, C.D., Brunning, R., Gale, R.P., Grever, M.R., Keating, M.J., Sawitsky, A., Stass, S., Weinstein, H. & Woods, W.G. (1990) Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. Journal of Clinical Oncology, 8, 813819.
  • Copelan, E.A., Biggs, J.C., Thompson, J.M., Crilley, P., Szer, J., Klein, J.P., Kapoor, N., Avalos, B.R., Cunningham, I., Atkinson, K., Downs, K., Harmon, G.S., Daly, M.B., Brodsky, I., Bulova, S.I. & Tutschka, P.J. (1991) Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood, 78, 838843.
  • Curtis, R.E., Rowlings, P.A., Deeg, H.J., Shriner, D.A., Socie, G., Travis, L.B., Horowitz, M.M., Witherspoon, R.P., Hoover, R.N., Sobocinski, K.A., Fraumeni, J.F. Jr & Boice, J.D. Jr (1997) Solid cancers after bone marrow transplantation. New England Journal of Medicine, 336, 897904.
  • Dastugue, N., Payen, C., Lafage-Pochitaloff, M., Bernard, P., Leroux, D., Huguet-Rigal, F., Stoppa, A.M., Marit, G., Molina, L., Michallet, M., Maraninchi, D., Attal, M. & Reiffers, J. (1995) Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia, 9, 14911498.
  • Deeks, J.J., Dinnes, J., D'Amico, R., Sowden, A.J., Sakarovitch, C., Song, F., Petticrew, M. & Altman, D.G. (2003) Evaluating non-randomised intervention studies. Health Technology Assessment, 7, iiix, 1–173.
  • Dillman, R.O., Davis, R.B., Green, M.R., Weiss, R.B., Gottlieb, A.J., Caplan, S., Kopel, S., Preisler, H., McIntyre, O.R. & Schiffer, C. (1991) A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. Blood, 78, 25202526.
  • Estey, E.H., Shen, Y. & Thall, P.F. (2000) Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t, and RAEB. Blood, 95, 7277.
  • Ferrant, A., Labopin, M., Frassoni, F., Prentice, H.G., Cahn, J.Y., Blaise, D., Reiffers, J., Visani, G., Sanz, M.A., Boogaerts, M.A., Lowenberg, B. & Gorin, N.C. (1997) Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Blood, 90, 29312938.
  • Gale, R.P., Horowitz, M.M., Weiner, R.S., Ash, R.C., Atkinson, K., Babu, R., Dicke, K.A., Klein, J.P., Lowenberg, B., Reiffers, J., Rimm, A.A., Rowlings, P.A., Sandberg, A.A., Sobocinski, K.A., Veum-Stone, J. & Bortin, M.M. (1995) Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplantation, 16, 203208.
  • Gale, R.P., Horowitz, M.M., Rees, J.K., Gray, R.G., Oken, M.M., Estey, E.H., Kim, K.M., Zhang, M.J., Ash, R.C., Atkinson, K., Champlin, R.E., Dicke, K.A., Gajewski, J.L., Goldman, J.M., Helbig, W., Henslee-Downey, P.S., Hinterberger, W., Jacobsen, N., Keating, A., Klein, J.P., Marmont, A.M., Prentice, H.G., Reiffers, J., Rimm, A.A., Rowlings, P.A., Sobocinski, K.A., Speck, B., Wingard, J.R. & Bortin, M.M. (1996) Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia, 10, 1319.
  • Gooley, T.A., Leisenring, W., Crowley, J. & Storer, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695706.
  • Gorin, N.C., Aegerter, P., Auvert, B., Meloni, G., Goldstone, A.H., Burnett, A., Carella, A., Korbling, M., Herve, P., Maraninchi, D., Lowenberg, R., Verdonck, L.F., de Planque, M., Hermans, J., Helbig, W., Porcellini, A., Rizzoli, V., Alesandrino, E.P., Franklin, I.M., Reiffers, J., Colleselli, P. & Goldman, J.M. (1990) Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood, 75, 16061614.
  • Gorin, N.C., Labopin, M., Meloni, G., Korbling, M., Carella, A., Herve, P., Burnett, A., Rizzoli, V., Alessandrino, E.P., Bjorkstrand, B., Ferrant, A., Lowenberg, B., Coser, P., Simonsson, B., Helbig, W., Mauri, S.B., Verdonck, L.F., Iriondo, A., Polli, E., Colombat, P., Franklin, I.M., Souillet, G. & Willemze, R. (1991) Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT). Leukemia, 5, 896904.
  • Gratwohl, A., Passweg, J., Baldomero, H. & Hermans, J. (1999) Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation, 24, 231245.
  • Graves, E.J. (1991) Detailed diagnoses and procedures, National Hospital Discharge Survey, 1989. Vital and Health Statistics, 13, 1236.
  • Harousseau, J.L., Cahn, J.Y., Pignon, B., Witz, F., Milpied, N., Delain, M., Lioure, B., Lamy, T., Desablens, B., Guilhot, F., Caillot, D., Abgrall, J.F., Francois, S., Briere, J., Guyotat, D., Casassus, P., Audhuy, B., Tellier, Z., Hurteloup, P. & Herve, P. (1997) Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood, 90, 29782986.
  • Hartman, A.R., Williams, S.F. & Dillon, J.J. (1998) Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis. Bone Marrow Transplantation, 22, 439443.
  • Hessner, M.J., Endean, D.J., Casper, J.T., Horowitz, M.M., Keever-Taylor, C.A., Roth, M., Flomenberg, N. & Drobyski, W.R. (1995) Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood, 86, 39873996.
  • International Bone Marrow Transplant Registry (1989) Transplant or chemotherapy in acute myelogenous leukaemia. International Bone Marrow Transplant Registry. Lancet, 1, 11191122.
  • Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine, 328, 593602.
  • Klein, J.P. & Moeschberger, J.L. (1997) Survival Analysis: Techniques for Censored and Truncated Data. pp. 334336, Springer, New York, USA.
  • Lamparelli, T., Van Lint, M.T., Gualandi, F., Occhini, D., Barbanti, M., Sacchi, N., Ficai, G., Ghinatti, C., Ferrara, G.B., Delfino, L., Pozzi, S., Morabito, A., Zikos, P., Vitale, V., Corvo, R., Frassoni, F. & Bacigalupo, A. (1997) Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience. Bone Marrow Transplantation, 20, 10571062.
  • Laporte, J.P., Douay, L., Lopez, M., Labopin, M., Jouet, J.P., Lesage, S., Stachowiak, J., Fouillard, L., Isnard, F., Noel-Walter, M.P., Pene, F., Deloux, J., Van Den Akker, J., Grande, M., Bauters, F., Najman, A. & Gorin, N.C. (1994) One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. Blood, 84, 38103818.
  • Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, F.R. & Willman, C.L. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood, 89, 33233329.
  • Linker, C.A., Damon, L.E., Ries, C.A., Navarro, W.A., Case, D. & Wolf, J.L. (2002) Autologous stem cell transplantation for advanced acute myeloid leukemia. Bone Marrow Transplantation, 29, 297301.
  • Litzow, M.R., Perez, W.S., Klein, J.P., Bolwell, B.J., Camitta, B., Copelan, E.A., Gale, R.P., Giralt, S.A., Keating, A., Lazarus, H.M., Marks, D.I., McCarthy, P.L., Miller, C.B., Milone, G., Prentice, H.G., Russell, J.A., Schultz, K.R., Trigg, M.E., Weisdorf, D.J. & Horowitz, M.M. (2002) Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. British Journal of Haematology, 119, 11151124.
  • Lowenberg, B., Downing, J.R. & Burnett, A. (1999) Acute myeloid leukemia. New England Journal of Medicine, 341, 10511062.
  • Mehta, J., Powles, R., Singhal, S., Horton, C., Tait, D. & Treleaven, J. (1996) Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Bone Marrow Transplantation, 18, 119123.
  • National Hospital Discharge Survey for 1990 (1992) (ed. by H.C.S.Branch), US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Hyattsville, MD, USA.
  • National Hospital Discharge Survey for 1991 (1993) (ed. by H.C.S.Branch), US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Hyattsville, MD, USA.
  • Petersdorf, E.W., Gooley, T.A., Anasetti, C., Martin, P.J., Smith, A.G., Mickelson, E.M., Woolfrey, A.E. & Hansen, J.A. (1998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood, 92, 35153520.
  • Phillips, G.L., Reece, D.E., Shepherd, J.D., Barnett, M.J., Brown, R.A., Frei-Lahr, D.A., Klingemann, H.G., Bolwell, B.J., Spinelli, J.J. & Herzig, R.H. (1991) High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of acute myelogenous leukemia in adults. Blood, 77, 14291435.
  • Ringden, O., Remberger, M., Persson, U., Ljungman, P., Aldener, A., Andstrom, E., Aschan, J., Bolme, P., Dahllof, G., Dalianis, T., Gahrton, G., Hägglund, H., Lönnqvist, B., Olerup, O., Shanwell, A., Sparrelid, E., Winiarski, J., Möller, E. & Öberg, M. (1995) Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplantation, 15, 619625.
  • Ringden, O., Labopin, M., Tura, S., Arcese, W., Iriondo, A., Zittoun, R., Sierra, J. & Gorin, N.C. (1996) A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). British Journal of Haematology, 93, 637645.
  • Ringden, O., Labopin, M., Gluckman, E., Hows, J.M., Bradley, B.A., Kolb, H.J., Fouillard, L., Jacobsen, N., Vernant, J.P., Witz, F., Harousseau, J.L. & Gorin, N.C. (1997) Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplantation, 19, 963968.
  • Sasazuki, T., Juji, T., Morishima, Y., Kinukawa, N., Kashiwabara, H., Inoko, H., Yoshida, T., Kimura, A., Akaza, T., Kamikawaji, N., Kodera, Y. & Takaku, F. (1998) Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. New England Journal of Medicine, 339, 11771185.
  • Schiller, G.J., Nimer, S.D., Territo, M.C., Ho, W.G., Champlin, R.E. & Gajewski, J.L. (1992) Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission. Journal of Clinical Oncology, 10, 4146.
  • Selvaggi, K.J., Wilson, J.W., Mills, L.E., Cornwell, G.G. III, Hurd, D., Dodge, W., Gingrich, R., Martin, S.E., McMillan, R., Miller, W. & Ball, E.D. (1994) Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow. Blood, 83, 16981705.
  • Sierra, J., Brunet, S., Granena, A., Olive, T., Bueno, J., Ribera, J.M., Petit, J., Besses, C., Llorente, A., Guardia, R., Macia, J., Rovira, M., Badell, I., Vela, E., Diaz de Heredia, C., Vivancos, P., Carreras, E., Feliu, E., Montserrat, E., Julia, A., Cubells, J., Rozman, C., Domingo, A. & Ortega, J.J. (1996) Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation. Journal of Clinical Oncology, 14, 13531363.
  • Sierra, J., Storer, B., Hansen, J.A., Bjerke, J.W., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Bryant, E., Chauncey, T.R., Sale, G., Sanders, J.E., Storb, R., Sullivan, K.M. & Anasetti, C. (1997) Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 42264235.
  • Sierra, J., Storer, B., Hansen, J.A., Martin, P.J., Petersdorf, E.W., Woolfrey, A., Matthews, D., Sanders, J.E., Storb, R., Appelbaum, F.R. & Anasetti, C. (2000) Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience. Bone Marrow Transplantation, 26, 397404.
  • Sievers, E.L., Appelbaum, F.R., Spielberger, R.T., Forman, S.J., Flowers, D., Smith, F.O., Shannon-Dorcy, K., Berger, M.S. & Bernstein, I.D. (1999) Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood, 93, 36783684.
  • Silberman, G., Crosse, M.G., Peterson, E.A., Weston, R.C., Horowitz, M.M., Appelbaum, F.R. & Cheson, B.D. (1994) Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. New England Journal of Medicine, 331, 10631067.
  • Stein, A.S., O'Donnell, M.R., Chai, A., Schmidt, G.M., Nademanee, A., Parker, P.M., Smith, E.P., Snyder, D.S., Molina, A., Stepan, D.E., Spielberger, R., Somlo, G., Margolin, K.A., Vora, N., Lipsett, J., Lee, J., Niland, J. & Forman, S.J. (1996) In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission. Journal of Clinical Oncology, 14, 22062216.
  • Tallman, M.S., Rowlings, P.A., Milone, G., Zhang, M.J., Perez, W.S., Weisdorf, D., Keating, A., Gale, R.P., Geller, R.B., Laughlin, M.J., Lazarus, H.M., Luger, S.M., McCarthy, P.L., Rowe, J.M., Saez, R.A., Vowels, M.R. & Horowitz, M.M. (2000) Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. Blood, 96, 12541258.
  • Wheatley, K. (2002) Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation? A statistician's view. British Journal of Haematology, 118, 351356.
  • Wiernik, P.H., Banks, P.L., Case, D.C. Jr, Arlin, Z.A., Periman, P.O., Todd, M.B., Ritch, P.S., Enck, R.E. & Weitberg, A.B. (1992) Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia. Blood, 79, 313319.
  • de Witte, T., Hermans, J., Vossen, J., Bacigalupo, A., Meloni, G., Jacobsen, N., Ruutu, T., Ljungman, P., Gratwohl, A., Runde, V., Niederwieser, D., van Biezen, A., Devergie, A., Cornelissen, J., Jouet, J.P., Arnold, R. & Apperley, J. (2000) Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). British Journal of Haematology, 110, 620630.
  • Zittoun, R.A., Mandelli, F., Willemze, R., de Witte, T., Labar, B., Resegotti, L., Leoni, F., Damasio, E., Visani, G., Papa, G., Caronia, F., Hayat, M., Stryckmans, P., Rotoli, B., Leoni, P., Peetermans, M.E., Dardenne, M., Vegna, M.L., Petti, M.C., Solbu, G. & Suciu, S. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. New England Journal of Medicine, 332, 217223.